Nomura Holdings
JUNO

Nomura Holdings’s Juno Therapeutics, Inc. JUNO Stock Holding History

Nomura Holdings’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,524
Closed -$322K – 1693
2017
Q1 		$322K Sell
14,524
-1,627
-10% -$34.9K ﹤0.01% 1065
2016
Q4 		$304K Buy
+16,151
New +$395K ﹤0.01% 1350

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings's JUNO Position: Q2 2017 in Review

Nomura Holdings sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2017, closing a stake of 14,524 shares — an estimated $322K sold.

Nomura Holdings first reported a position in JUNO in Q4 2016 and held it in 2 quarters. The position peaked at $322K in Q1 2017. 173 funds tracked by Wall St. Rank hold JUNO as of Q2 2017.

  • Nomura Holdings reported no remaining Juno Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Nomura Holdings sold 14,524 Juno Therapeutics, Inc. shares in Q2 2017, an estimated $322K.
  • Nomura Holdings first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 2 quarters.
  • Nomura Holdings's Juno Therapeutics, Inc. position peaked at $322K in Q1 2017.
  • 173 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2017.

Based on Nomura Holdings's 13F filing for Q2 2017, filed 15 Aug 2017.